Combined use of emapalumab and ruxolitinib in a patient with refractory hemophagocytic lymphohistiocytosis was safe and effective.
Michael P TriebwasserDavid M BarrettHamid BassiriNancy BuninCaitlin W ElgartenJason FreedmanAbdallah S GeeraDimitri MonosMichele P LambertTimothy OlsonAlix E SeifMichele PaesslerWhitney PetrosaAnne F ReillyNeil RombergKathleen E SullivanGhazal Z QuinnEdward BehrensDavid Trent TeacheyPublished in: Pediatric blood & cancer (2021)
Keyphrases